0001209191-23-023772.txt : 20230407 0001209191-23-023772.hdr.sgml : 20230407 20230407161530 ACCESSION NUMBER: 0001209191-23-023772 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230407 DATE AS OF CHANGE: 20230407 EFFECTIVENESS DATE: 20230407 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Harpoon Therapeutics, Inc. CENTRAL INDEX KEY: 0001708493 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473458693 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-478285 FILM NUMBER: 23808908 BUSINESS ADDRESS: STREET 1: 131 OYSTER POINT BOULEVARD STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-443-7400 MAIL ADDRESS: STREET 1: 131 OYSTER POINT BOULEVARD STREET 2: SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001708493 Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA CALIFORNIA 94080 (650) 443-7400 DELAWARE None None Corporation true Julie Eastland c/o Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Joseph Bailes c/o Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA CALIFORNIA 94080 Director Mark Chin c/o Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA CALIFORNIA 94080 Director Alan Colowick c/o Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA CALIFORNIA 94080 Director Jonathan Drachman c/o Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA CALIFORNIA 94080 Director Ronald Hunt c/o Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA CALIFORNIA 94080 Director Scott Myers c/o Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA CALIFORNIA 94080 Director Andrew Robbins c/o Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA CALIFORNIA 94080 Director Lauren P. Silvernail c/o Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA CALIFORNIA 94080 Director Joanne Viney c/o Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA CALIFORNIA 94080 Director Luke Nathaniel Walker c/o Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA CALIFORNIA 94080 Executive Officer Biotechnology $25,000,001 - $100,000,000 06b false 2023-03-23 false true true true 8.000% Series A Redeemable Preferred Stock and Warrants to Purchase Common Stock false 0 25000000 25000000 0 false 6 0 0 0 true The Company intends to use the net proceeds to complete its ongoing clinical studies, working capital and other general corporate purposes. false Harpoon Therapeutics, Inc. /s/ Julie Eastland Julie Eastland President and Chief Executive Officer 2023-04-07